Merck Buys Contract Manufacturing Org Avecia To Advance Biologics Strategy
This article was originally published in The Pink Sheet Daily
Executive Summary
With the acquisition, Merck gains a contract manufacturing organization with specific expertise in microbial-derived biologics.